Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, discusses how providers discuss the Oncology Care Model (OCM) with patients and the questions they ask about it.
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, discusses how providers discuss the Oncology Care Model (OCM) with patients and the questions they ask about it.
Transcript
How do providers discuss the concept of the OCM with patients, and what questions do patients ask about it?
One of the requirements of the OCM, or Oncology Care Model, is to make sure the patients receive what they call the beneficiary letters. The beneficiary letter is actually a letter to the patient who has qualified to be eligible for the Oncology Care Model patient care. When the patients actually receive this—either in the mail, or most of our practices actually give it during their visit and they say you’re now a member of this—they always ask, “What is this?” and “Am I going to pay extra for this?” And then now they understand they’re actually getting more and that this is a benefit from Medicare and they are like, “Medicare is giving me more? How much is this going to cost in my premiums?” No ma’am or sir, this isn’t going to cost you anything.
Those are really most of the questions that we get: whether the co-pay is going to go up, whether they’re going to get a raise in their premiums, and what are those benefits that they are not getting now that this particular service is going to offer them. Those are most of the questions we get about OCM.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More